Pricing Log in Create free account

BioCardia, Inc. (BCDA) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

BioCardia, Inc. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. BioCardia, Inc. and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($14.0M and $13.5M). Across the 6 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 4 and BioCardia, Inc. on 2.

Valuation

Metric BCDA RADX Biotechnology median
P/E n/m — 10.60
P/S 24.58 — 9.40
P/B 3.90 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 28.74 n/m 9.02
Earnings yield (87.99%) — (32.88%)
Free cash flow yield (71.97%) 0.00% (23.13%)

Profitability

Metric BCDA RADX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,803.19%) 0.00% (51.96%)
Return on assets (214.47%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCDA RADX Biotechnology median
Revenue growth (TTM) 0.71% — 6.76%
EPS growth (last fiscal year) 57.59% (1.97%) 29.88%
Revenue growth, 5-year CAGR 26.89% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BCDA RADX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.09 1.16 4.97
Net debt to EBITDA 0.30 0.08 1.01

Dividend

Metric BCDA RADX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BCDA RADX Biotechnology median
Market cap 13.47m 13.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack